Bioject Inc.


May 09, 07

NEW STORY
17:06 ET Bioject Reports First Quarter 2007 Financial Results

 
May 04, 07

16:25 ET Bioject to Report First Quarter 2007 Financial Results

 
Mar 27, 07

17:50 ET Bioject Reports December 31, 2006 Financial Results

 
Mar 26, 07

12:30 ET Bioject Developed Canine Melanoma Device for Merial Ltd.

 
Mar 21, 07

16:26 ET Bioject to Report Fourth Quarter and Year End 2006 Financial Results

 
Mar 07, 07

07:00 ET Bioject Delivers Multi-Dose Needle-Free Devices for Production Animals to Merial

 
Jan 04, 07

07:00 ET NIH Utilizes Biojector(R) 2000 in Avian Influenza Study

 
Dec 15, 06

07:00 ET Bioject Completes Debt Financing with Partners for Growth

 
Nov 07, 06

09:30 ET Bioject Signs Agreement With Vical

 
Nov 01, 06

16:30 ET Bioject Reports Third-Quarter 2006 Results

 
Oct 31, 06

10:16 ET Bioject Expands Development Agreement With Leading European Biotechnology Company

 
Oct 26, 06

16:33 ET Bioject to Report Third Quarter 2006 Financial Results

 
Oct 20, 06

16:43 ET Bioject CEO to Retire at Year End

 
Oct 09, 06

07:00 ET Bioject Advances in Vaccine Delivery With Biojector(R) 2000

 
Oct 06, 06

16:30 ET Bioject Receives Notice from the Nasdaq Stock Market Regarding Non-Compliance With the Minimum Bid Price Rule

 
Oct 03, 06

07:00 ET Bioject Expands Contract With the Centers for Disease Control for Global Immunization Device

 
Aug 21, 06

16:30 ET Bioject Announces Filing Quarterly Report on Form 10-Q

 
Aug 15, 06

17:07 ET Bioject Announces Delay in Filing Quarterly Report on Form 10-Q

 
Aug 02, 06

16:42 ET Bioject Reports Second-Quarter 2006 Financial Results

 
Jul 27, 06

16:30 ET Bioject to Report Second Quarter 2006 Financial Results

 
Jun 01, 06

16:50 ET Bioject Completes Financing and Signs Agreement

 
May 19, 06

17:01 ET Bioject Medical Technologies Inc. to Webcast Annual Shareholders' Meeting on Wednesday, May 24, 2006

 
May 03, 06

16:39 ET Bioject Reports First Quarter 2006 Financial Results

 
Apr 26, 06

16:30 ET Bioject to Report First Quarter Financial Results

 
Apr 07, 06

16:30 ET Bioject Receives Going Concern Opinion

 
Mar 15, 06

16:37 ET Bioject Reports December 31, 2005 Financial Results

 
Mar 10, 06

16:30 ET Bioject to Report Fourth Quarter 2005 Financial Results

 
Mar 08, 06

19:30 ET Bioject Announces Convertible Debt Financing

 
Jan 09, 06

08:30 ET Bioject Signs Additional Project Agreements With Merial

 
Nov 29, 05

08:30 ET Bioject to Develop a Disposable Cartridge Jet Injection System for Global Immunizations

 
Nov 22, 05

08:30 ET Bioject Receives Small Business Innovation Research (SBIR) Contract From CDC

 
Oct 26, 05

16:10 ET Bioject Reports Third-Quarter 2005 Results

 
Oct 19, 05

16:30 ET Bioject to Report Third Quarter 2005 Financial Results

 
Oct 18, 05

16:30 ET Bioject Announces B2000 Technology to Be Used in Phase 2 NIH-Sponsored Clinical Trial for HIV Vaccine

 
Oct 11, 05

16:30 ET Bioject Signs Development Agreement With Leading European Biotechnology Company

 
Jul 27, 05

16:30 ET Bioject Reports Second-Quarter 2005 Financial Results

 
Jul 20, 05

16:30 ET Bioject to Report Second Quarter 2005 Financial Results

 
Jun 06, 05

17:05 ET Bioject Medical Technologies Inc. to Webcast Annual Shareholders' Meeting on Thursday, June 9, 2005

 
Apr 27, 05

16:30 ET Bioject Reports First Quarter 2005 Financial Results Product Sales Increase 42.9%

 
Apr 20, 05

16:30 ET Bioject to Report First Quarter 2005 Financial Results

 
Feb 28, 05

16:30 ET Bioject Reports December 31, 2004 Financial Results

 
Feb 22, 05

16:30 ET Bioject to Report Fourth Quarter 2004 Financial Results

 
Feb 04, 05

08:46 ET Bioject and Chronimed/StatScript Announce Supply Agreement

 
Dec 16, 04

08:31 ET Bioject Receives Milestone Payment From Merial

 
Nov 17, 04

08:30 ET Bioject Announces Strategic $2.4 Million Private Placement

 
Oct 27, 04

17:01 ET Bioject Reports Third-Quarter 2004 Results

 
Oct 20, 04

09:01 ET Bioject Signs License Agreement With Leading Japanese Pharmaceutical Company

 
Sep 09, 04

10:00 ET Bioject Signs Supply Agreement for Needle-Free Vial Adapter Product

 
Jul 28, 04

16:30 ET Bioject Reports Second-Quarter 2004 Results

 
Jul 19, 04

09:01 ET Bioject Signs Agreement With Path to Develop and Evaluate a Disposable- Cartridge Jet Injection System for Global Immunization

 
Jun 21, 04

18:00 ET Bioject Clarifies Elan's Holdings of Bioject Stock

 
Apr 28, 04

16:30 ET Bioject Reports First-Quarter 2004 Results

 
Mar 18, 04

09:01 ET Bioject Signs Additional License and Supply Agreement with Merial for Needle-Free Injector System for Companion Animals

 
Mar 03, 04

16:30 ET Bioject Reports December 31, 2003 Financial Results

 
Dec 15, 03

16:30 ET Bioject Announces Completion of Phase I Study Comparing the Iject(TM) Pre- Filled, Needle-Free Drug Delivery System to Traditional Needle-And-Syringe

 
Dec 08, 03

17:00 ET Bioject Announces National Institutes of Health Begins Human Ebola Vaccine Trial Utilizing Biojector(R) 2000

 
Nov 05, 03

16:30 ET Bioject Medical Technologies Inc. To Present at The Wall Street Analyst Forum

 
Oct 27, 03

17:00 ET Bioject Reports Third-Quarter 2003 Results

 
Sep 18, 03

07:45 ET Webcast Alert: Bioject Medical Technologies Inc Announces BJCT Presentation at Redchip Partners Fall New York Investor Conference 2003 Webcast

 
Sep 12, 03

07:45 ET Webcast Alert: Bioject Medical Technologies Inc Announces BJCT Presentation at Redchip Partners Fall New York Investor Conference 2003 Webcast

 
Jul 29, 03

17:00 ET Bioject Reports Second-Quarter 2003 Results

 
Jun 18, 03

07:30 ET Bioject Signs Services and Supply Agreement With The National Institutes of Health

 
Apr 23, 03

16:31 ET Bioject Reports First-Quarter 2003 Results

 
Apr 03, 03

08:30 ET Webcast Alert: Bioject Medical Technologies Inc. Announce BJCT Presentation at Redchip Partners New York Investor Conference 2003 Webcast

 
07:00 ET Webcast Alert: Bioject Medical Technologies Inc. Announce BJCT Presentation at Redchip Partners New York Investor Conference 2003 Webcast

 
Mar 19, 03

08:30 ET Bioject Medical Technologies Inc. to Present at Investing in Healthcare Conference

 
Mar 11, 03

16:30 ET Bioject Signs Supply Agreement for Needle-Free Vial Adapter Product

 
Mar 04, 03

18:00 ET Bioject Medical Technologies Inc. to Present at Invest Northwest 2003

 
Feb 26, 03

16:30 ET Bioject Reports December 31, 2002 Financial Results

 
Feb 14, 03

17:00 ET Bioject Medical Technologies Inc. to Be Featured on Weekly Business Television News Magazine Show Business Now

 
Nov 06, 02

07:30 ET Bioject Medical Technologies Inc. to Present at The Wall Street Analyst Forum

 
Oct 24, 02

16:30 ET Bioject Reports Second-Quarter 2003 Results

 
Aug 15, 02

09:01 ET Bioject Announces License and Supply Agreement With Merial

 
Jul 25, 02

07:31 ET Bioject Reports First-Quarter Fiscal 2003 Results

 
Jul 02, 02

07:00 ET Bioject Medical Technologies Adopts Shareholder Rights Agreement

 
May 23, 02

07:31 ET Bioject Reports Fiscal 2002 Results

 
May 16, 02

18:00 ET Bioject to Report Fiscal 2002 Fourth-Quarter and Year-End Financial Results On May 23, 2002

 
May 07, 02

07:30 ET Bioject Hires Two Senior Level Executives

 
Mar 20, 02

13:30 ET Bioject Medical Technologies Inc. to Present at The New York Society Of Security Analysts Sixth Annual Health Care Conference

 
Feb 27, 02

12:41 ET Bioject Medical Technologies, Inc. Investor Conference Call Webcast

 
Feb 26, 02

19:30 ET Bioject Announces That Amgen Elects Not to Pursue Development And Commercialization Under Licensing Agreements

 
Feb 07, 02

16:30 ET Bioject Medical Technologies Inc. to Present at the Wall Street Analyst Forum On Thursday, February 14, 2002 at 10:50 a.m. EST

 
Jan 24, 02

07:03 ET Bioject Reports Third-Quarter Fiscal 2002 Results

 
Jan 17, 02

18:30 ET Bioject Schedules Conference Call to Discuss Third-Quarter Fiscal 2002 Results

 
15:35 ET Memorial-Sloan Kettering Signs Agreement With Bioject for Use of Bioject's B2000 Needle-Free Injection System in DNA Vaccine Research

 
Dec 20, 01

14:06 ET Bioject Completes Equity Financing

 
Dec 14, 01

07:00 ET Bioject Announces Agreement Regarding Elan Stock

 
Dec 13, 01

07:00 ET Bioject Signs Additional Agreement With Amgen for Needle-Free Injection Systems

 
Nov 21, 01

07:00 ET Bioject Shareholders Approve Issuance of Stock and Ratification of Amended and Restated Articles

 
Nov 08, 01

07:02 ET Bioject Announces Special Shareholder Meeting

 
Oct 25, 01

07:01 ET Bioject Reports Second Quarter Fiscal 2002 Results

 
Oct 23, 01

07:03 ET National Institute of Health Utilizes Bioject'S Needle-Free Injection System For Its DNA AIDS Vaccine Study

 
Oct 19, 01

07:00 ET Bioject Board Authorizes Redemption of all Series A Preferred Stock

 
Oct 16, 01

07:01 ET Bioject and Alkermes Sign License and Development Agreement

 
Oct 01, 01

16:45 ET Bioject Exercises Series A Preferred Redemption Right

 
Sep 27, 01

07:00 ET Bioject Announces Conference Call and Webcast for Business Update

 
Sep 25, 01

07:00 ET Bioject Hires Two Senior Executives

 
Jul 26, 01

08:04 ET Bioject Reports First Quarter 2002 Results

 
Jul 25, 01

08:02 ET Bioject Announces Results of Influenza Vaccine Study and Updates Vaccine Research Program

 
May 24, 01

11:50 ET Bioject Completes $15 Million Equity Financing

 
May 22, 01

09:15 ET Bioject Reports Fiscal 2001 Results

 
Mar 28, 01

01:00 ET Bioject and Serono Receive FDA Market Clearance for Needle-Free Device To Deliver Serostim(R) Human Growth Hormone for AIDS Wasting

 
Jan 25, 01

09:15 ET Bioject Reports Third Quarter Fiscal 2001 Results

 
Jan 10, 01

08:04 ET Bioject and Serono Announce Launch of First Needle-Free Growth Hormone Injection System in Canada

 
Nov 02, 00

09:15 ET Bioject Reports Second Quarter Fiscal 2001 Results

 
Oct 16, 00

01:00 ET Bioject and Serono Expand Agreement for Growth Hormone Injection System

 
Sep 06, 00

10:47 ET U.S. Navy Begins Additional Clinical Trial of Malaria DNA Vaccine With Bioject Delivery System

 
Aug 04, 00

08:00 ET Bioject Completes Equity Financing

 
08:00 ET Bioject Reports First Quarter 2001 Results

 
Jul 28, 00

08:00 ET Bioject Closes $10 Million Equity Financing

 
Jun 26, 00

01:00 ET Bioject Receives FDA Market Clearance for First Needle-Free Device to Deliver Serono's Saizen(R) Human Growth Hormone for US Pediatric Market

 
May 26, 00

08:00 ET Bioject Reports Fiscal 2000 Results - Net Loss Narrowed and Cash Position Improved -

 
Apr 04, 00

08:00 ET Bioject and Animal Medical Center Introduce DNA Vaccine for the Treatment of Melanoma in Animals

 
Mar 01, 00

19:04 ET Bioject Announces Development and Clinical Supply Agreement with Amgen

 
Jan 06, 00

17:12 ET Bioject Medical Technologies, Inc., and Serono Laboratories, Inc. Announce Agreement for Needle-Free Delivery of Saizen(R) Human Growth Hormone

 
Dec 21, 99

08:00 ET U.S. Navy Reports Positive Preliminary Results with Biojector(R) 2000 Device In Phase I Malaria DNA Vaccine Trial

 
Nov 11, 99

08:03 ET Bioject Receives CE Mark For Needle-Free Jet Injection Systems

 
Nov 05, 99

08:00 ET Bioject Reports Second Quarter Fiscal 2000 Results; Net Loss Continues to Decline

 
Nov 02, 99

07:30 ET Bioject to Resume Trading Under Symbol 'BJCT' Effective Immediately

 
Oct 19, 99

08:01 ET Bioject Medical Technologies Inc. and AngioSense, Inc. Form a Collaborative Alliance; Alliance focused on Cardiovascular Angiogenesis and Gene Therapy Applications

 
Oct 12, 99

08:00 ET Bioject Announces Temporary Ticker Symbol

 
Sep 28, 99

14:35 ET Bioject Transfers Listing to Nasdaq SmallCap Market; Shareholders and Board of Directors Approve a 1-for-5 Reverse Stock Split

 
Sep 09, 99

11:34 ET Bioject Establishes Technology Agreement with Major Biotechnology Company

 
Aug 20, 99

08:30 ET Bioject Announces Management Change

 
Aug 04, 99

08:31 ET Bioject Reports First Quarter Fiscal 2000 Results

 
Jul 02, 99

07:00 ET Bioject Reports Sale of its GlucoTrax(TM) Technology

 
Jun 25, 99

09:00 ET Bioject Reports Fiscal 1999 Results

 
May 12, 99

11:37 ET Biojector(R) 2000 Device Evaluated in Malaria DNA Vaccine Phase I Trial

 
Apr 12, 99

20:20 ET Bioject Announces Preferred Stock Purchase by Elan

 
Mar 16, 99

16:56 ET Bioject Initiates Human Clinical Trials Delivering DNA-Based Vaccines for The Treatment of Lymphoma

 
Feb 23, 99

16:30 ET Bioject Announces Termination of Negotiations with Merck & Co.

 
Jan 26, 99

16:30 ET Bioject Reports Third Quarter Fiscal 1999 Results

 
Nov 24, 98

12:47 ET Bioject Announces Receipt of Second Payment from Merck & Co.

 
Nov 17, 98

16:15 ET Bioject Appoints President of Joint Venture with Elan; The Company Expands Marketing for Blood Glucose Monitoring System

 
Nov 03, 98

16:30 ET Bioject Reports Second Quarter Fiscal 1999 Results

 
Aug 13, 98

16:50 ET Bioject Reports First Quarter Fiscal 1999 Results

 
Jul 22, 98

17:51 ET Bioject and GeneMedicine Announce Research Collaboration

 
Jul 13, 98

08:51 ET Bioject Enters Vaccine Agreement With Merck

 
May 21, 98

21:36 ET Bioject Reports Fourth Quarter and Full Year Fiscal 1998 Results

 
Apr 20, 98

08:38 ET Bioject Appoints New CFO

 
Apr 09, 98

10:04 ET Bioject Acquires Vitajet in an All-Stock Transaction

 
Mar 26, 98

20:16 ET Bioject Announces Resignation of Chief Financial Officer

 
Feb 12, 98

19:05 ET Bioject Reports Third Quarter Fiscal 1998 Results

 
Jan 12, 98

10:40 ET Illinois State Department of Health Selects Biojector 2000 to Support Statewide Emergency Needs Program

 
Oct 01, 97

08:40 ET Bioject Medical Technologies To Host Analyst Conference Call To Discuss Joint Venture With Elan Corporation

 
08:37 ET Bioject Medical Technologies and Elan Corporation Form Joint Venture and Drug Delivery Alliance

 
Sep 24, 97

07:30 ET Group Health Cooperative Offers Biojector(R) 2000 Needle-Free Injections

 
Jul 30, 97

16:28 ET Bioject Reports Improved Fiscal 1998 First Quarter Performance

 
Jun 24, 97

07:55 ET Bioject Announces New Directors

 
Jun 03, 97

16:00 ET Bioject Reports Improved Fiscal 1997 Performance

 
May 28, 97

07:55 ET Bioject Announces Flu Program Partnership With Wal-Mart

 
Mar 04, 97

08:31 ET New Mexico State Dept. of Health - Public Health Division to Offer Needle-Free Immunizations (Statewide Program)

 
Feb 13, 97

08:31 ET Oklahoma State Dept. of Health to Offer Needle-Free Immunizations

 
Feb 04, 97

08:30 ET Bioject Reports Improved Performance for Fiscal 1997 Third Quarter

 
Jan 28, 97

08:35 ET Bioject Announces Cancellation of Contract With Schering AG

 
Dec 17, 96

08:55 ET Bioject to Supply Needle-Free Injections to New York City Health Department

 
Dec 12, 96

08:55 ET Bioject Announces Private Placement Raising $2 Million

 
Oct 31, 96

11:33 ET Bioject Reports Improved Performance for Fiscal 1997 Second Quarter

 
Sep 16, 96

11:20 ET Bioject Management Comments on Stock Trading/Provides Update

 
Aug 01, 96

08:55 ET BIOJECT REPORTS IMPROVED FISCAL 1997 FIRST QUARTER PERFORMANCE

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2007 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.